
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting PRPK and TOPK for skin cancer prevention and therapy
Eunmiri Roh, Mee‐Hyun Lee, Tatyana A. Zykova, et al.
Oncogene (2018) Vol. 37, Iss. 42, pp. 5633-5647
Open Access | Times Cited: 29
Eunmiri Roh, Mee‐Hyun Lee, Tatyana A. Zykova, et al.
Oncogene (2018) Vol. 37, Iss. 42, pp. 5633-5647
Open Access | Times Cited: 29
Showing 1-25 of 29 citing articles:
T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics
Katharine Herbert, Thomas M. Ashton, Remko Prevo, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 11
Open Access | Times Cited: 68
Katharine Herbert, Thomas M. Ashton, Remko Prevo, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 11
Open Access | Times Cited: 68
Ultraviolet (UV) radiation: a double-edged sword in cancer development and therapy
Zhen-wei Yu, Min Zheng, Hua‐yang Fan, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 6
Zhen-wei Yu, Min Zheng, Hua‐yang Fan, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 6
PBK/TOPK: An Effective Drug Target with Diverse Therapeutic Potential
Hai Huang, Mee‐Hyun Lee, Kangdong Liu, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2232-2232
Open Access | Times Cited: 31
Hai Huang, Mee‐Hyun Lee, Kangdong Liu, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2232-2232
Open Access | Times Cited: 31
Sinomenine Inhibits TOPK To Ameliorate Psoriasiform Dermatitis
Hui Lu, Fanfan Zeng, Hongjian Gong, et al.
ACS Omega (2025)
Open Access
Hui Lu, Fanfan Zeng, Hongjian Gong, et al.
ACS Omega (2025)
Open Access
Acetylshikonin suppressed growth of colorectal tumour tissue and cells by inhibiting the intracellular kinase, T‐lymphokine‐activated killer cell‐originated protein kinase.
Ran Zhao, Bu Young Choi, Lixiao Wei, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 10, pp. 2303-2319
Open Access | Times Cited: 28
Ran Zhao, Bu Young Choi, Lixiao Wei, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 10, pp. 2303-2319
Open Access | Times Cited: 28
PBK phosphorylates MSL1 to elicit epigenetic modulation of CD276 in nasopharyngeal carcinoma
Mengyao Wang, Bin Qi, Fang Wang, et al.
Oncogenesis (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 26
Mengyao Wang, Bin Qi, Fang Wang, et al.
Oncogenesis (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 26
Alternative Options for Skin Cancer Therapy via Regulation of AKT and Related Signaling Pathways
Sun‐Young Hwang, Jung‐Il Chae, Ah‐Won Kwak, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6869-6869
Open Access | Times Cited: 27
Sun‐Young Hwang, Jung‐Il Chae, Ah‐Won Kwak, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6869-6869
Open Access | Times Cited: 27
Protective effects of glycycoumarin on liver diseases
Enxiang Zhang, Shutao Yin, Shuang Zhao, et al.
Phytotherapy Research (2019) Vol. 34, Iss. 6, pp. 1191-1197
Closed Access | Times Cited: 23
Enxiang Zhang, Shutao Yin, Shuang Zhao, et al.
Phytotherapy Research (2019) Vol. 34, Iss. 6, pp. 1191-1197
Closed Access | Times Cited: 23
Xanthohumol inhibits non‐small cell lung cancer via directly targeting T‐lymphokine‐activated killer cell‐originated protein kinase
Shuang Zhao, Jinling Cui, Lixing Cao, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 7, pp. 3057-3068
Closed Access | Times Cited: 7
Shuang Zhao, Jinling Cui, Lixing Cao, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 7, pp. 3057-3068
Closed Access | Times Cited: 7
Glycyrol exerts potent therapeutic effect on lung cancer via directly inactivating T-LAK cell-originated protein kinase
Shangyun Lu, Linhu Ye, Shutao Yin, et al.
Pharmacological Research (2019) Vol. 147, pp. 104366-104366
Closed Access | Times Cited: 22
Shangyun Lu, Linhu Ye, Shutao Yin, et al.
Pharmacological Research (2019) Vol. 147, pp. 104366-104366
Closed Access | Times Cited: 22
Small‐molecule inhibitor HI‐TOPK‐032 improves NK‐92MI cell infiltration into ovarian tumours
Mengqi Deng, Ruiye Yang, Qi Sun, et al.
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 134, Iss. 5, pp. 629-642
Closed Access | Times Cited: 2
Mengqi Deng, Ruiye Yang, Qi Sun, et al.
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 134, Iss. 5, pp. 629-642
Closed Access | Times Cited: 2
Crystal structure of the human PRPK–TPRKB complex
Jian Li, Xinli Ma, Surajit Banerjee, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 15
Jian Li, Xinli Ma, Surajit Banerjee, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 15
Suppression of the solar ultraviolet-induced skin carcinogenesis by TOPK inhibitor HI-TOPK-032
Eunmiri Roh, Yaping Han, Kanamata Reddy, et al.
Oncogene (2020) Vol. 39, Iss. 21, pp. 4170-4182
Open Access | Times Cited: 16
Eunmiri Roh, Yaping Han, Kanamata Reddy, et al.
Oncogene (2020) Vol. 39, Iss. 21, pp. 4170-4182
Open Access | Times Cited: 16
Are FDA-Approved Sunscreen Components Effective in Preventing Solar UV-Induced Skin Cancer?
Ann M. Bode, Eunmiri Roh
Cells (2020) Vol. 9, Iss. 7, pp. 1674-1674
Open Access | Times Cited: 15
Ann M. Bode, Eunmiri Roh
Cells (2020) Vol. 9, Iss. 7, pp. 1674-1674
Open Access | Times Cited: 15
T‐LAK cell‐originated protein kinase (TOPK) is a Novel Prognostic and Therapeutic Target in Chordoma
Pichaya Thanindratarn, Dylan C. Dean, Scott D. Nelson, et al.
Cell Proliferation (2020) Vol. 53, Iss. 10
Open Access | Times Cited: 12
Pichaya Thanindratarn, Dylan C. Dean, Scott D. Nelson, et al.
Cell Proliferation (2020) Vol. 53, Iss. 10
Open Access | Times Cited: 12
3-Deoxysappanchalcone Inhibits Skin Cancer Proliferation by Regulating T-Lymphokine-Activated Killer Cell-Originated Protein Kinase in vitro and in vivo
Xiaorong Fu, Ran Zhao, Goo Yoon, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 11
Xiaorong Fu, Ran Zhao, Goo Yoon, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 11
Orobol, 3′-hydroxy-genistein, suppresses the development and regrowth of cutaneous SCC
Eunmiri Roh, Jong‐Eun Kim, Tianshun Zhang, et al.
Biochemical Pharmacology (2023) Vol. 209, pp. 115415-115415
Closed Access | Times Cited: 4
Eunmiri Roh, Jong‐Eun Kim, Tianshun Zhang, et al.
Biochemical Pharmacology (2023) Vol. 209, pp. 115415-115415
Closed Access | Times Cited: 4
Innovative Rocuronium Bromide Topical Formulation for Targeted Skin Drug Delivery: Design, Comprehensive Characterization, In Vitro 2D/3D Human Cell Culture and Permeation
Victor H. Ruiz, David Encinas-Basurto, Bo Sun, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8776-8776
Open Access | Times Cited: 4
Victor H. Ruiz, David Encinas-Basurto, Bo Sun, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8776-8776
Open Access | Times Cited: 4
Expression of Concern: T‐LAK cell‐originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcoma
Pichaya Thanindratarn, Ran Wei, Dylan C. Dean, et al.
Molecular Oncology (2021) Vol. 15, Iss. 12, pp. 3721-3737
Open Access | Times Cited: 8
Pichaya Thanindratarn, Ran Wei, Dylan C. Dean, et al.
Molecular Oncology (2021) Vol. 15, Iss. 12, pp. 3721-3737
Open Access | Times Cited: 8
The role of T-LAK cell-originated protein kinase in targeted cancer therapy
Lu Zhang, Fei Wang, Huijun Yi, et al.
Molecular and Cellular Biochemistry (2022) Vol. 477, Iss. 3, pp. 759-769
Closed Access | Times Cited: 6
Lu Zhang, Fei Wang, Huijun Yi, et al.
Molecular and Cellular Biochemistry (2022) Vol. 477, Iss. 3, pp. 759-769
Closed Access | Times Cited: 6
Hui Lu, Yingze Huang, Xiaofang Ni, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 38, Iss. 5, pp. 851-863
Closed Access | Times Cited: 3
Omics- and Pharmacogenomic Evidence for the Prognostic, Regulatory, and Immune-Related Roles of PBK in a Pan-Cancer Cohort
Yi Liu, Juan Xiang, Gang Peng, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 6
Yi Liu, Juan Xiang, Gang Peng, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 6
<p>microRNA-26a Directly Targeting MMP14 and MMP16 Inhibits the Cancer Cell Proliferation, Migration and Invasion in Cutaneous Squamous Cell Carcinoma</p>
Zheng Wang, Zong-Yu Li, Delai Zhao, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 7087-7095
Open Access | Times Cited: 5
Zheng Wang, Zong-Yu Li, Delai Zhao, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 7087-7095
Open Access | Times Cited: 5
Bestatin Cream Impairs Solar Simulated Light‒Driven Skin Inflammation and Skin Carcinogenesis in Mice
Simin Zhao, Ke Yao, Kangdong Liu, et al.
Journal of Investigative Dermatology (2021) Vol. 141, Iss. 11, pp. 2699-2709.e2
Open Access | Times Cited: 5
Simin Zhao, Ke Yao, Kangdong Liu, et al.
Journal of Investigative Dermatology (2021) Vol. 141, Iss. 11, pp. 2699-2709.e2
Open Access | Times Cited: 5
Scutellarin Suppresses RPMI7951 Melanoma Cell Proliferation by Targeting TOPK
Xin Mu, Lijuan Wang, Zixi Zhang, et al.
Anti-Cancer Agents in Medicinal Chemistry (2020) Vol. 21, Iss. 5, pp. 640-648
Closed Access | Times Cited: 4
Xin Mu, Lijuan Wang, Zixi Zhang, et al.
Anti-Cancer Agents in Medicinal Chemistry (2020) Vol. 21, Iss. 5, pp. 640-648
Closed Access | Times Cited: 4